Gene search


Sequence information


Select Gene Cds Cds_length GC_content Pep Pep_length
Apr5g1302 ATGAGTAGCTTGGTGGAGAGGCTTCGTGTAAGATCAGATCGCAAGCCAATTTATAATATTGATGAGTCAGATGATGATGCTGATTTTTTGCCAAGAAAATCTGGGACAACACAGGAAAAATTAGAGAGGATAGTGAGAAGTGATGCGAAAGAAGATTCATGTCAAACTTGTGGAGAAAGTGAAAATCTTCTGAGCTGTGAAACTTGCACATATGCTTACCATCCTAGATGTTTAGTTCCACCACTTAAAGGTCCCCTTCCAGGCAATTGGAGGTGCCCTGAATGTGTTAGCCCACTTAATGATATTGATAAGATATTAGATTGTGAGATGCGTCCCACTGTAGCCGCTGACAATGATGCCACAAAATTAGGGTCAAAGCAAATTTTTGTCAAACAATATCTTGTTAAGTGGAAGGGACTATCATATTTACATTGCACATGGGTGCCAGAGAAAGAGTTTTTGAAAGCATTCAAAACTCATCCTCGTCTTAAGACCAAAGTGAACAACTTCCATCAAAAAATGGCATCTGTCAATACTTCTGATGAAGACTTTGTTGCTATTCGACCTGAATGGACTACGGTTGATCGAATACTTGCTTGCAGGGGTGGTGATGATGAGCGAGAATATCTTGTGAAGTGGAAAGAGCTTCCTTATGATGAATGCTATTGGGAGTTTGAGTCGGATATTTCTGCATTTCAGCCAGAAATAGAAAGATTCAATAGATTTCGGTCTAGATCCAGCAAATTTTCTTCTAGTAAACAAAAAAGCAGTGTTAAGGATGATGCTGAATTGAGGAAACATCAGAAAGAATTTCAACAATATGAACATAGCCCTGAGTTTCTTTCAGGTACACTTCACCCATATCAGCTTGAAGGCTTGAACTTCCTACGATTCTCTTGGTCCAAGCAAACTCATGTTATACTTGCTGATGAAATGGGACTGGGAAAAACCATTCAAAGCATTGCTTTCTTAGCATCCCTTTTTGAAGAGGGCGTCTACCCCCATCTAGTGGTTGCTCCACTTTCAACATTGCGAAACTGGGAACGTGAATTTGCAACATGGGCACCTCAAATGAATGTGCTTATGTATGTTGGATCTGCCCAAGCTCGCAGTGTCATAAGAGAGTATGAATTTTACTTTCCGAAGAAACAGAAGAAGATCAAGAAAAAGAAATCTGGTCAGATAATTAGTGAAAGCAAGCAAGAAAGGATCAAGTTTGATGTCCTTTTGACTTCATATGAAATGATCAACTTTGACACAGCATCATTGAAACCTATAAAATGGGAGTGCATGATAGTTGATGAAGGTCACCGTCTCAAAAATAAAGATTCAAAATTATTTTCTTCATTGAAGCAGTATTCTAGCAGACATCGTGTTCTCTTGACTGGAACTCCTCTTCAGAACAACTTGGATGAACTTTTTATGCTTATGCACTTCCTTGATGCTGGGAAGTTTGGAAGTTTAGAGGAGTTCCAGGAAGAGTTTAAGGATATCAATCAAGAGGAACAGATCTCAAGGCTTCATAAGATGTTGGCCCCACATCTCCTGCGAAGAGTGAAGAAAGATGTCATGAAGGAGCTACCACCTAAAAAGGAACTTATTCTACGTATTGAATTGAGCAGCAAACAGAAAGAATATTATAAGGCGATTTTAACCCGTAATTATCAGATATTAACTCGTCGTGGTGGTGCACAGATTTCTCTTATCAATGTTGTTATGGAACTGCGTAAGCTCTGTTGTCATCCTTACATGTTAGAAGGAGTTGAACCAGATATTGATGATCCAAAAGAATCATACAAACAGTTGCTGGAATCATCGGGAAAGTTGCAATTGCTGGACAAGATGATGGTGAAGCTTAAAGAGCAAGGACATAGAGTCCTCATATATTCCCAATTTCAGCACATGCTGGACTTGCTTGAGGATTACTGTTCTTACAAGAATTGGCAGTATGAGAGGATAGATGGCAAGGTTGGTGGAGCTGAAAGACAAGTTCGCATAGATCGTTTTAATGCCAAAAATTCTTCAAGATTTTGCTTTCTGCTTTCTACTAGAGCTGGGGGATTGGGGATAAACCTTGCAACTGCTGACACAGTTATTATATATGATAGTGATTGGAATCCTCATGCTGATTTACAAGCTATGGCTAGAGCTCATCGACTTGGACAAACTAACAAGGTGTTAATTTATAGGCTTATAACACGAGGAACTATTGAAGAAAGGATGATGCAGATGACTAAGAAGAAAATGGTGTTGGAACACCTAGTTGTAGGGAGGCTAAAGGCTCAAAATATCAACCAGGAAGAGTTGGATGACATCATAAGGTATGGTTCAAAAGAGTTATTTGCAGATGAGAATGATGAAGCAGGCAAATCCCGTCAAATCCATTATGATGCTGCTGCTATTGACAGATTGCTAGATCGTGATCAAGTTGGAGATGAAGAGGCTACTTTGGATGATGAAGAAGAAGATGGATTTTTGAAGGCCTTTAAGGTTGCAAATTTTGAGTATGTTGATGAGGTTCAGGCTGCAGCAGAAGAAGAGGCAGCACAAAAAAGAGCAATGGAGACTCTGAACAGTTCAGAAAGAACGCATTACTGGGAGGAGTTGTTAAAAGACAGGTATCAAGAGCATAAAGTTGAGGAGTTTAATGCCTTAGGCAAAGGGAAGCGAAACCGCAAGCTGATGGTTTCTGTTGAGGAGGATGACCTTGCTGGTCTGGAAGATGTAAGCTCTGACGGGGAAGATGACAATTATGAAGCAGATCTTACAGATGGTGATTCAAATTCTACTGGAACTGCTACTATTAGAAGGCCTTATAAAAAGAAAGCACGTGATAGCACAGAGCCACTTCCTCTGATGGAAGGGGAAGGAAAAGCATTCAGAGTGCTTGGTTTTAATCAAAATCAGAGGGCTGCATTTGTGCAAATTTTGATGAGGTTTGGAGTTGGTGATTTTGATTGGAAGGAGTTTACTTCCCGGATGAAGCAGAAGACTTATGAAGAAATCAAAGATTATGGAACCCTTTTCCTGTCTCATATTGCTGAAGATATAACTGATTCCTCTACATTCACAGATGGTGTTCCCAAAGAAGGACTCCGAATCCAAGATGTACTTGTTAGGATTGCAGTTCTGCTCTTGATAAGGGACAAGGTGAAGTTTGCATCACAACATTCTCAAACAACATTGTTTTCGGATGACATCTTATTACGCTATCCAGGTTTGAAGGGTGCAAAGATATGGAAGGAGGAGCATGATTTAGTTTTACTGCGTGCTGTTTTGAAGCATGGGTATGGAAGGTGGCAAGCTATTGTTGATGATAAGGATCTGAAGATTCAGGAGGTCATATGCCAGGAGTTGAATCTTCCCTTTATAAATTTACCAGTGCAAGGACAAGTTGGCTCTCAGGCACAAAATGGAGCAAATTTGACAAATGCGGAAGTACCCAGCAATCAATCTAGGGAAAATGGTGGGGGTGACATAACTGCGGATGGTGCACAAGGTTCTGGTGATGCTAGGAACCAAGCACAGTTATATCAGGACTCCTCCATATTATATCATTTTAGAGACATGCAGAGAAGACAGGTTGAGTTTATAAAAAAGAGGGTTCTTCTCTTGGAAAAAGGGCTTAATGCAGAGTATCAGAAAGAATATTTTGGTGATCCTAAAGCAAATGAAGTAACAAATGAAGAACTGAAAAGTGAACTCAAGGCTACAAATATTCCTAGTTATAAATTAGGGGACACAGACACCCAAATGATTGATCATCTGCCGCAAGTTGAAACAATAGCTTCTGAAGAAATTTTGGTTGCTTGTGATAATGATCCAAATCGACTGGAATTAGTTCGACTTTACAATGAGATGTGCAAGGTAGTGGAGGAAAACCCCATGGATTTAGTTCAAACTTCTTTGACAAGAGAACCAGCAGAGATCAATGGGGTTAAGAATTTCCCTCCGCTAGAAACCATTTGTGAAGAAATCAACAGAATTCTAACACCCGCACAAGAACAACCTATTTCAGAAATGCCAATATCAAATTCAGATAACAAATCAGAGGTTATATCACACGGTGAAGTTGTGGGCTCCAAGTCGCTGCCAATCCCTCAAGATGACAGCAAACGTGATGATTCAACGGACAACCAGAGTAAAGATATGATAATAGAATCTGAACTTAAAAACGAAAGCAGCTCAAGCTTGGTAAAAGAAATTAATGAAACACCGAGTCTTCCGGAGAAAGAGGAAAGTAATACAGAAATGGATGAAACTAAGAATGATGCTCCGTTGAATGAAAACCCAGAGAAATCTGATGCTGGGGTCATTGTATTGGATGATTAA 4332 0.398 MSSLVERLRVRSDRKPIYNIDESDDDADFLPRKSGTTQEKLERIVRSDAKEDSCQTCGESENLLSCETCTYAYHPRCLVPPLKGPLPGNWRCPECVSPLNDIDKILDCEMRPTVAADNDATKLGSKQIFVKQYLVKWKGLSYLHCTWVPEKEFLKAFKTHPRLKTKVNNFHQKMASVNTSDEDFVAIRPEWTTVDRILACRGGDDEREYLVKWKELPYDECYWEFESDISAFQPEIERFNRFRSRSSKFSSSKQKSSVKDDAELRKHQKEFQQYEHSPEFLSGTLHPYQLEGLNFLRFSWSKQTHVILADEMGLGKTIQSIAFLASLFEEGVYPHLVVAPLSTLRNWEREFATWAPQMNVLMYVGSAQARSVIREYEFYFPKKQKKIKKKKSGQIISESKQERIKFDVLLTSYEMINFDTASLKPIKWECMIVDEGHRLKNKDSKLFSSLKQYSSRHRVLLTGTPLQNNLDELFMLMHFLDAGKFGSLEEFQEEFKDINQEEQISRLHKMLAPHLLRRVKKDVMKELPPKKELILRIELSSKQKEYYKAILTRNYQILTRRGGAQISLINVVMELRKLCCHPYMLEGVEPDIDDPKESYKQLLESSGKLQLLDKMMVKLKEQGHRVLIYSQFQHMLDLLEDYCSYKNWQYERIDGKVGGAERQVRIDRFNAKNSSRFCFLLSTRAGGLGINLATADTVIIYDSDWNPHADLQAMARAHRLGQTNKVLIYRLITRGTIEERMMQMTKKKMVLEHLVVGRLKAQNINQEELDDIIRYGSKELFADENDEAGKSRQIHYDAAAIDRLLDRDQVGDEEATLDDEEEDGFLKAFKVANFEYVDEVQAAAEEEAAQKRAMETLNSSERTHYWEELLKDRYQEHKVEEFNALGKGKRNRKLMVSVEEDDLAGLEDVSSDGEDDNYEADLTDGDSNSTGTATIRRPYKKKARDSTEPLPLMEGEGKAFRVLGFNQNQRAAFVQILMRFGVGDFDWKEFTSRMKQKTYEEIKDYGTLFLSHIAEDITDSSTFTDGVPKEGLRIQDVLVRIAVLLLIRDKVKFASQHSQTTLFSDDILLRYPGLKGAKIWKEEHDLVLLRAVLKHGYGRWQAIVDDKDLKIQEVICQELNLPFINLPVQGQVGSQAQNGANLTNAEVPSNQSRENGGGDITADGAQGSGDARNQAQLYQDSSILYHFRDMQRRQVEFIKKRVLLLEKGLNAEYQKEYFGDPKANEVTNEELKSELKATNIPSYKLGDTDTQMIDHLPQVETIASEEILVACDNDPNRLELVRLYNEMCKVVEENPMDLVQTSLTREPAEINGVKNFPPLETICEEINRILTPAQEQPISEMPISNSDNKSEVISHGEVVGSKSLPIPQDDSKRDDSTDNQSKDMIIESELKNESSSSLVKEINETPSLPEKEESNTEMDETKNDAPLNENPEKSDAGVIVLDD* 1444
       

Annotation information


Select Seq ID Length Analysis Description Start End IPR GO
Apr5g1302 1443 SMART DUF1087_2 839 905 IPR009463 -
Apr5g1302 1443 MobiDBLite consensus disorder prediction 1334 1352 - -
Apr5g1302 1443 CDD CD2_tandem 190 239 - -
Apr5g1302 1443 Pfam CHD subfamily II, SANT-like domain 933 1065 IPR009462 GO:0003677|GO:0006338
Apr5g1302 1443 Pfam Helicase conserved C-terminal domain 608 721 IPR001650 -
Apr5g1302 1443 MobiDBLite consensus disorder prediction 1405 1429 - -
Apr5g1302 1443 Gene3D Zinc/RING finger domain, C3HC4 (zinc finger) 44 97 IPR013083 -
Apr5g1302 1443 Pfam SNF2-related domain 305 585 IPR000330 GO:0005524|GO:0140658
Apr5g1302 1443 PANTHER CHD3-TYPE CHROMATIN-REMODELING FACTOR PICKLE 5 1054 - -
Apr5g1302 1443 SMART PHD_3 53 96 IPR001965 -
Apr5g1302 1443 SUPERFAMILY Chromo domain-like 178 242 IPR016197 -
Apr5g1302 1443 CDD SF2_C_SNF 606 732 - -
Apr5g1302 1443 SMART chromo_7 190 244 IPR000953 -
Apr5g1302 1443 SMART chromo_7 99 162 IPR000953 -
Apr5g1302 1443 ProSiteProfiles Superfamilies 1 and 2 helicase C-terminal domain profile. 611 772 IPR001650 -
Apr5g1302 1443 Gene3D - 1035 1213 - -
Apr5g1302 1443 MobiDBLite consensus disorder prediction 1334 1443 - -
Apr5g1302 1443 SUPERFAMILY Chromo domain-like 66 177 IPR016197 -
Apr5g1302 1443 MobiDBLite consensus disorder prediction 1145 1170 - -
Apr5g1302 1443 ProSiteProfiles Superfamilies 1 and 2 helicase ATP-binding type-1 domain profile. 297 483 IPR014001 -
Apr5g1302 1443 Pfam PHD-finger 54 96 IPR019787 -
Apr5g1302 1443 SMART ultradead3 281 494 IPR014001 -
Apr5g1302 1443 MobiDBLite consensus disorder prediction 905 922 - -
Apr5g1302 1443 CDD CD1_tandem 98 171 - -
Apr5g1302 1443 Gene3D - 282 527 IPR038718 -
Apr5g1302 1443 PANTHER CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 3-RELATED-RELATED 5 1054 - -
Apr5g1302 1443 ProSitePatterns Zinc finger PHD-type signature. 54 95 IPR019786 -
Apr5g1302 1443 Gene3D - 528 752 IPR027417 -
Apr5g1302 1443 ProSiteProfiles Zinc finger PHD-type profile. 51 98 IPR019787 -
Apr5g1302 1443 SMART DUF1086_2 910 1068 IPR009462 GO:0003677|GO:0006338
Apr5g1302 1443 MobiDBLite consensus disorder prediction 905 950 - -
Apr5g1302 1443 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 269 518 IPR027417 -
Apr5g1302 1443 MobiDBLite consensus disorder prediction 1367 1389 - -
Apr5g1302 1443 Pfam Chromo (CHRromatin Organisation MOdifier) domain 193 241 IPR023780 -
Apr5g1302 1443 Pfam Chromo (CHRromatin Organisation MOdifier) domain 103 157 IPR023780 -
Apr5g1302 1443 ProSiteProfiles Chromo and chromo shadow domain profile. 192 254 IPR000953 -
Apr5g1302 1443 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 520 776 IPR027417 -
Apr5g1302 1443 Pfam CHD subfamily II, DUF1087 844 902 IPR009463 -
Apr5g1302 1443 ProSiteProfiles Chromo and chromo shadow domain profile. 100 182 IPR000953 -
Apr5g1302 1443 Gene3D - 98 189 - -
Apr5g1302 1443 Gene3D - 190 241 - -
Apr5g1302 1443 SMART helicmild6 637 721 IPR001650 -
       

Duplication type information


Select Gene Chromosome Start End Duplicated_type
Apr5g1302 Apr-Chr5 17332100 17352543 Dispersed/Wgd
       

Functional genes information


Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Apr5g1302 307 782 RAD5 or RAD16-like Gene Family AT1G02670 23.741 1.12e-30 128
       

Transcription factors information


Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
TR PHD Apr5g1302 SNF2_N 1.4e-65 CL0023
       

Pathway information


Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Apr5g1302 K11643 - gmx:100790230 2574.27
       

Event-related genes


Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Apr9g0213 9 2765090 2790373 Apr5g1302 5 17332100 17352543 PCT